UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000059590
Receipt number R000068103
Scientific Title Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals
Date of disclosure of the study information 2025/11/11
Last modified on 2025/11/10 12:14:50

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals

Acronym

Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals

Scientific Title

Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals

Scientific Title:Acronym

Examination of the Change in Quality of Life through an Environmental Sensor-Based Stress Estimation and Coping Feedback System for Healthy Individuals

Region

Japan


Condition

Condition

No specific disease identified

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine changes in self-administered questionnaire scores related to quality of life before and after independent individuals living alone use a system that estimates four emotional states (stress, arousal, fatigue, and comfort) with high accuracy through artificial intelligence (AI) based on data collected from non-contact environmental sensors installed in their rooms and contact-type wristband sensors worn for two months. The system provides feedback on the estimated emotional states as well as guidance on coping strategies for physical and chemical stressors via the free messaging application offered by LINE Corporation.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Health-related QOL: SF-36 (Medical Outcomes Study 36-Item Short-Form Health Survey)

Key secondary outcomes

QOL assessment: EQ-5D-5L (EuroQol 5 Dimensions 5-Level), 5 items

Mood assessment: Profile of Mood States, Second Edition (POMS 2), Adult Short Form

Brief Job Stress Questionnaire (BJSQ): 29 items on stress responses (from the original 57-item version)

Checklist for Activities of Daily Living for Preventive Care (25 items)

Japanese version of the Client Satisfaction Questionnaire (CSQ-8J), 8 items


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Participants will receive approximately one hour of instruction on the feedback system that utilizes sensors and the free messaging application LINE (provided by LINE Corporation), followed by approximately one hour to complete self-administered questionnaires assessing quality of life and related factors before the intervention.
After that, for a period of two months, participants will place the developed environmental sensors in their rooms and wear a wristband-type sensor in their daily lives. They will receive daily feedback for about 15 minutes via the LINE application on a loaned smartphone (mobile device).
After the two-month intervention period, participants will again complete post-intervention questionnaires, which will take approximately one hour to finish.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Adults aged 18 years or older
2. Individuals living alone in a private independent-type retirement home
3. Individuals certified as independent not requiring support or nursing care according to the eight-level classification of care needs - that is not certified as Support Level from 1 to 2 or Care Level from 1 to 5
4. Individuals capable of placing environmental sensors in their rooms and using a wristband-type sensor
5. Individuals able to receive messages via the messaging application on the loaned smartphone mobile device
6. Individuals who after receiving a full explanation of the study demonstrate adequate understanding and provide written informed consent of their own free will to participate

Key exclusion criteria

1. Individuals who have serious illnesses or conditions with activity limitations that, in the judgment of the investigators, may affect the participants' safety or the conduct of this study (cancer, heart disease, severe respiratory disease, severe endocrine disease, stroke, dementia, physical disability, intellectual disability, mental disorder, alcohol dependence, or other serious progressive physical illnesses)
2. Individuals who are currently participating in another study

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Shimizu

Organization

Graduate School of Medicine, Chiba University

Division name

Cognitive Behavioral Physiology

Zip code

2608670

Address

1-8-1 Inohana, Chuo-ku, Chiba, Chiba Prefecture, Japan

TEL

0432262069

Email

eiji@faculty.chiba-u.jp


Public contact

Name of contact person

1st name Eiji
Middle name
Last name Shimizu

Organization

Graduate School of Medicine, Chiba University

Division name

Cognitive Behavioral Physiology

Zip code

2608670

Address

1-8-1 Inohana, Chuo-ku, Chiba, Chiba Prefecture, Japan

TEL

0432262069

Homepage URL


Email

eiji@faculty.chiba-u.jp


Sponsor or person

Institute

Graduate School of Medicine, Chiba University, Cognitive Behavioral Physiology

Institute

Department

Personal name



Funding Source

Organization

Ministry of Internal Affairs and Communications

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Graduate School of Medicine, Chiba University

Address

1-8-1 Inohana, Chuo-ku, Chiba, Chiba Prefecture, Japan

Tel

0432262069

Email

eiji@faculty.chiba-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 11 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 08 Month 15 Day

Date of IRB


Anticipated trial start date

2025 Year 12 Month 01 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 10 Month 30 Day

Last modified on

2025 Year 11 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000068103